UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
ASML
ASML
$655B
| $667K | ﹤0.01% |
6,183
-137
| -2% | -$13.9K |
|
1727
Applied Industrial Technologies
AIT
$13.3B
| $666K | ﹤0.01% |
14,599
+800
| +6% | +$37.4K |
|
1728
Chemed
CHE
$7.18B
| $666K | ﹤0.01% |
6,300
| – | – |
|
1729
Ironwood Pharmaceuticals
IRWD
$701M
| $666K | ﹤0.01% |
51,935
-239
| -0.5% | -$2.73K |
|
1730
Clearway Energy Class C
CWEN
$6.74B
| $665K | ﹤0.01% |
28,200
+11,400
| +68% | +$265K |
|
1731
SAP
SAP
$230B
| $663K | ﹤0.01% |
9,519
-2,519
| -21% | -$173K |
|
|
AKS
1732
DELISTED
AK Steel Holding Corp
AKS
| $663K | ﹤0.01% |
111,595
+5,100
| +5% | +$32.1K |
|
|
CYS
1733
DELISTED
CYS Investments Inc.
CYS
| $662K | ﹤0.01% |
75,895
+4,700
| +7% | +$42.1K |
|
1734
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $661K | ﹤0.01% |
21,396
+152
| +0.7% | +$4.58K |
|
|
ARIA
1735
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $660K | ﹤0.01% |
95,994
| – | – |
|
1736
Molina Healthcare
MOH
$10B
| $658K | ﹤0.01% |
12,299
+800
| +7% | +$38.7K |
|
|
UBA
1737
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $658K | ﹤0.01% |
30,058
+1,000
| +3% | +$21.8K |
|
|
PIR
1738
DELISTED
Pier 1 Imports, Inc.
PIR
| $657K | ﹤0.01% |
2,132
+160
| +8% | +$42.6K |
|
1739
B2Gold
BTG
$5.45B
| $656K | ﹤0.01% |
399,968
-162,812
| -29% | -$296K |
|
|
COHR
1740
DELISTED
Coherent Inc
COHR
| $656K | ﹤0.01% |
10,800
| – | – |
|
|
TFM
1741
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $656K | ﹤0.01% |
15,912
+1,100
| +7% | +$41.8K |
|
1742
Scansource
SCSC
$1.16B
| $655K | ﹤0.01% |
16,316
+1,000
| +7% | +$37.6K |
|
|
GTY
1743
Getty Realty Corp
GTY
$2.06B
| $653K | ﹤0.01% |
36,295
+2,025
| +6% | +$36K |
|
|
GK
1744
DELISTED
G&K Services Inc
GK
| $652K | ﹤0.01% |
9,200
+700
| +8% | +$44.4K |
|
1745
Buckle
BKE
$2.36B
| $651K | ﹤0.01% |
12,399
+800
| +7% | +$39.3K |
|
1746
Kaiser Aluminum
KALU
$2.8B
| $650K | ﹤0.01% |
9,099
+500
| +6% | +$36.1K |
|
1747
Precigen
PGEN
$2.47B
| $650K | ﹤0.01% |
24,693
+6,068
| +33% | +$133K |
|
1748
JD.com
JD
$44.3B
| $649K | ﹤0.01% |
+28,033
| New | +$691K |
|
1749
Mine Safety
MSA
$7.48B
| $648K | ﹤0.01% |
12,199
+700
| +6% | +$37K |
|
|
EXPR
1750
DELISTED
Express, Inc.
EXPR
| $648K | ﹤0.01% |
2,202
+160
| +8% | +$46.2K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.